Psiquiatras, psicanalistas e os psicofármacos - historiando na direção de um reposicionamento
Palavras-chave:
Psicofármacos, DSM-III, psiquiatria fenomenológicaResumo
Este artigo propõe, a partir da história da psiquiatria e da psicanálise, pensar um mais além do antagonismo entre elas. Essa condição se faz necessária para a abertura de novos contextos onde os efeitos dos psicofármacos podem também ser percebidos e analisados.
Downloads
Referências
Dalzell T. (2007). Eugen Bleuler 150: Bleuler’s reception of Freud, History of Psychiatry, London, vol. 18, n. 4, p. 471-482.
Decker H. (2007). How Kraepelinian was Kraepelin? How Kraepelinian are the neo-Kraepelinians? – from Emil Kraepelin to DSM-III, History of Psychiatry, London, vol. 18, n. 3, p. 337-360.
Fédida P. (1997). A química e o psíquico. Um desafio para a psicanálise, Boletim de novidades, São Paulo, vol. 10, n. 99, p. 51-54.
____. (2002). Dos benefícios da depressão: elogio da psicoterapia. São Paulo: Escuta.
Freud S. (1916/1917). Conferência xvi Psicanálise e Psiquiatria. In Edição standard brasileira das obras psicológicas completas de Sigmund Freud. Rio de Janeiro: Imago, v. XVI.
____. (1940). Esboço de psicanálise. In Edição standard brasileira das obras psicológicas completas de Sigmund Freud. Rio de Janeiro: Imago, V. XXIII.
Green A. (1966). La psychopharmacologie: ouvertures, impasses, perspectives, Évolution Psychiatrique, France, vol. 31, n. 4, p. 681-705.
Guyotat,J. (1970). Aspects de narcissisme dans lês psychoses (reflexions à partir d’expériences de thérapie institutionnelle et de certaines chimiothérapies), Évolution Psychiatrique, France, vol. 35, n. 2, p. 321-342.
Healy D. (2000). Some continuities and discontinuities in the pharmacotherapy of nervous conditions before and after chlorpromazine and imipramine, History of Psychiatry, England, XI, p. 393-412.
Hirschmüller A. (1999) The development of psychiatry and neurology in the nineteenth century, History of Psychiatry, England, X, p. 395-423.
Jablensky A. (2007). Living in a Kraepelinian world: Kraepelin’s impact on modern psychyatry, History of Psychiatry, London, vol. 18, n. 3, p. 381-388.
Jeanneau A. (2007). Entre psychopharmacologie et métapsychologie. Un espace inexploré. Revue Française de Psychanalyse, France, vol. 2, n. 71, p. 389-399.
____. (1980). Mouvements psychiatriques et psychopharmacologie. Entre l’affect et la représentation, L’Evolution psychiatrique, France, vol. 45, n. 4, p. 691-703.
Koppe S. (2009). Neurosis: aspects of its conceptual development in nineteenth century, History of Psychiatry, London, vol. 20, n. 1, p. 27-46.
Kuhn R. (1989). The Discovery of modern antidepressants, Psychiatr J Univ Ottawa, Canadá, vol. 14, n. 1, p. 249-252.
Maatz A.; Hoff P. (2014). The birth of schizophrenia or a very modern Bleuler: a close reading of Eugen Bleuler’s “Die Prognose der Dementia praecox” and a re-consideration of his contribution to psychiatry, History of Psychiatry, London, vol. 25, n. 4, p. 431-440.
Mayes R.; Horwitz A. (2005). DSM-III and the revolution in the classification of mental illness, Journal of the History of the Behavioral Sciences, EUA, vol. 41, n. 3, p. 249-267.
Martin S. (2007). Between Kraepelin and Freud: the integrative psychiatry of August Hoch, History of Psychiatry, London, vol. 18, n. 3, p. 275-299.
Minard M. (2013). Le DSM-ROI, La psychiatrie américaine et la fabrique des diagnostics. Toulouse: Érès.
Minard M. (2004). Politique, économie et psychiatrie, Sud/Nord, France, vol. 1, n. 19, p. 75-98.
Moncrieff J. (1999). An investigation into the precedents of modern drug treatment in psychiatry, History of Psychiatry, England, x, p. 475-490.
Plant R. (2005). William Menninger and American psychoanalysis, 1946-48, History of Psychiatry, London, vol. 16, n. 2, p. 181-202.
Prüll C. (1999). City and country in German psychiatry in the nineteenth and twentieth centuries – the example of Freiburg, History of Psychiatry, England, X, p. 439-474.
Rasmussen N. (2006). Making the first antidepressant: amphetamine in American medicine, 1929-1950, Journal of the history of medicine and allied sciences, U.K., vol. 61, n. 3, p. 288-323.
Sadowsky J. (2005). Beyond the metaphor of the pendulum: eletroconvulsive therapy, psychoanalysis, and the styles of american psychiatry, Journal of the history of medicine and allied sciences, U.K., vol. 61, n. 1, p. 1-25.
Sarwer-Foner G. (1959). The role of neuroleptic medication in psychotherapeutic interaction, Read at the New York American Psychiatric Association Divisional Meeting, Nov. 28.
Scull A. (2010). The mental health sector and the social sciences in post-World War II USA. Part 1: Total war and its aftermath, History of Psychiatry, London, vol. 22, n. 1, p. 3-19.
____. (2011). The mental health sector and the social sciences in post-World War II USA. Part 2: The impact of federal research funding and the drugs revolution, History of Psychiatry, London, vol. 22, n. 3, p. 268-284.
Southard E. (2007). Non-dementia non-praecox: note on the advantages to mental hygiene of extirpating a term, History of Psychiatry, London, vol.18, n. 4, p. 483-502.
Tatossian A. (2006). A fenomenologia das psicoses. São Paulo: Escuta.
assinepercurso@uol.com.br